Demystifying Medicine Video

This video discusses the three COVID-19 variants of concern, explaining why they are concerning, what they mean for vaccine success, and the future of this pandemic.

For more resources please see:

[Please complete our feedback form]

Author Details


  • Association of State and Territorial Health Officials (ASTHO). (2021, January 31). Pfizer and Moderna Vaccine Comparison [Fact sheet].
  • Glatter, M. (2020). Dry Air Indoors Will Increase Transmission Of Covid-19 As Winter Approaches. Journal of Medical Ethics.
  • Koyama, T., Weeraratne, D., Snowdon, J. L., & Parida, L. (2020). Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment. Pathogens.
  • Lui, Y., Liu, J., Xia, H., Zhang, H., Fontes-Garfias, CR., Swanson, KA., Cui, H., Sarkar, R., Chen, W., Cutler, M., Cooper, D., Weaver, SC., Muik, A., Sahin, U., Jansen, KU., Xie, X., Dormitzer, PR., & Shi, P. (2021). Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report. New England Journal of Medicine.
  • Mahase, E. (2021). Covid-19 Novavax vaccine efficacy is 86% against UL variant and 60% against South African variant. British Journal of Medicine.
  • Ministry of Health. (2020, December 30). Information Sheet Pfizer-BioNTech and Moderna COVID-19 Vaccines [Fact sheet].
  • Moderna. (2021, January 35). Moderna COVID-19 Vaccien Retains Neutralizaing Activity Agsint Emerging Variants First Identified in the U.K. and the Republic of South Africa. [Press release].
  • Muik, A., Wallisch, A., Sänger, B., Swandon, KA., Mühl, J., Chen, W., Cai, H., Maurus, D., Sarkar, R., Türeci, O., Dormitzer, PR., & Sahin, U. (2021). Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science.
  • Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91–98. doi: 10.1016/j.jare.2020.03.005
  • Wise, J. (2021) Covid-19: THe E484K mutation and the risk it poses. British Journal of Medicine.

Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at